Company profile

Royal DSM specializes in the development, manufacture and marketing of performance materials, and nutritional and pharmaceutical ingredients. The products are used in a wide range of end-markets and applications, such as human and animal nutrition and health, personal care, pharmaceuticals, automotive and transport, coatings and paint, housing and electrics & electronics. Net sales (not including sold divisions) by family of products and services break down as follows:
  • nutritional ingredients (66.2%): vitamins, enzymes, carotenoids, food ingredients, benzoates, etc. for the cosmetic, food, and animal nutrition industries;
  • performance materials (31.4%): elastomers, resins, plastics, etc.;
  • biomedical and biotechnological products (1.9%);
  • other (0.5%).
Net sales break down geographically as follows: the Netherlands (24.8%), Europe (37.7%), America (21.4%), China (10.1%), Japan (1.2%), India (1%), Asia (2.8%) and other (1%).

Source: Cofisem - Last Update: 17 Jan 2020
Key Executives
Chairman of the Management Board Feike Sijbesma
Member of the Management Board de Vreeze Dimitri
Member of the Management Board Geraldine Matchett
Chief Financial Officer Geraldine Matchett
VP, Investor Relations Dave Huizing
Source: Cofisem - Last Update: 22 Nov 2019
Key figures
Millenium 2018 2017 2016 2015 2014
Net sales 9.267.000 8.632.000 7.920.000 8.935.000 9.181.000
Income from ordinary activities 9.267.000 8.632.000 7.920.000 8.935.000 9.181.000
Operating income 1.245.000 846.000 657.000 304.000 263.000
Cost (net) of financial indebtedness -95.000 -119.000 -106.000 -141.000 -125.000
Equity-accounted companies' contribution to results 129.000 1.154.000 194.000 30.000 59.000
Net profit from discontinued activities 0 30.000
Net income 1.079.000 1.781.000 629.000 92.000 101.000
Net income (Group share) 1.077.000 1.769.000 621.000 88.000 147.000
Fiscal year end 12,18 12,17 12,16 12,15 12,14
Length of fiscal year (month) 12 12 12 12 12
Currency & Unit EUR - thousands EUR - thousands EUR - thousands EUR - thousands EUR - thousands
Account Standards
Source: Cofisem - Last Update: 17 Jan 2020
Shareholder information
Capital Group Cos Inc 9,20 %
BlackRock, Inc. 4,70 %
EuroPacific Growth Fund 3,70 %
Vanguard Group Inc 3,10 %
Artisan Partners Limited Partnership 2,00 %
NN Group N.V. 1,90 %
Source: Cofisem - Last Update: 25 Nov 2019

Address

Royal DSM

1 Het Overloon
PO Box 6500
NL-6411 TE Heerlen
Netherlands
Source: Cofisem - Last Update: 17 Jan 2020

Contact

Dave Huizing
Phone number: +31 45 578 2864
Source: Royal DSM - Last Update: 17 Jan 2020